Pascal Veillon

671 total citations
23 papers, 478 citations indexed

About

Pascal Veillon is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Pascal Veillon has authored 23 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Hepatology and 5 papers in Rheumatology. Recurrent topics in Pascal Veillon's work include Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (12 papers). Pascal Veillon is often cited by papers focused on Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (12 papers). Pascal Veillon collaborates with scholars based in France, Mauritania and Switzerland. Pascal Veillon's co-authors include F. Lunel, Françoise Lunel‐Fabiani, Christopher Payan, Alexandra Ducancelle, Paul Calès, Gastón Picchio, Catherine Gaudy, A Goudeau, Ségolène Brichler and Emmanuel Gordien and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Journal of Hepatology.

In The Last Decade

Pascal Veillon

23 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Veillon France 13 407 362 51 50 34 23 478
Christopher Marshall United States 8 344 0.8× 338 0.9× 37 0.7× 57 1.1× 68 2.0× 9 602
Amal Gad Egypt 9 258 0.6× 274 0.8× 26 0.5× 52 1.0× 37 1.1× 14 412
V Weich Germany 11 325 0.8× 350 1.0× 51 1.0× 22 0.4× 33 1.0× 21 480
Montserrat Maldonado‐González Mexico 11 332 0.8× 305 0.8× 28 0.5× 37 0.7× 34 1.0× 26 432
M. Willems Belgium 11 215 0.5× 257 0.7× 37 0.7× 42 0.8× 36 1.1× 12 354
Galia Askarieh Sweden 8 262 0.6× 311 0.9× 85 1.7× 43 0.9× 28 0.8× 11 438
Zu-Yau Lin Taiwan 16 589 1.4× 607 1.7× 51 1.0× 35 0.7× 44 1.3× 28 684
T Sodeyama Japan 10 439 1.1× 464 1.3× 31 0.6× 19 0.4× 43 1.3× 19 536
I. Lonjon France 8 495 1.2× 482 1.3× 49 1.0× 46 0.9× 57 1.7× 9 622
R. Stemerowicz Germany 8 349 0.9× 386 1.1× 44 0.9× 40 0.8× 20 0.6× 12 478

Countries citing papers authored by Pascal Veillon

Since Specialization
Citations

This map shows the geographic impact of Pascal Veillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Veillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Veillon more than expected).

Fields of papers citing papers by Pascal Veillon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Veillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Veillon. The network helps show where Pascal Veillon may publish in the future.

Co-authorship network of co-authors of Pascal Veillon

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Veillon. A scholar is included among the top collaborators of Pascal Veillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Veillon. Pascal Veillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillou‐Guillemette, Hélène Le, et al.. (2024). Prevalence, clinical and virological characteristics and short‐term prognosis of hepatitis delta infection among patients with HIV/HBV in Nouakchott, Mauritania. Journal of Viral Hepatitis. 31(8). 457–465. 1 indexed citations
2.
Pivert, Adeline, et al.. (2021). From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study. Vaccine. 39(16). 2274–2279. 1 indexed citations
3.
Lefeuvre, Caroline, Adeline Pivert, Hélène Le Guillou‐Guillemette, et al.. (2020). Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France. Journal of Infection. 81(2). 248–254. 34 indexed citations
4.
Veillon, Pascal, I. Fouchard‐Hubert, Dominique Larrey, et al.. (2015). Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?. Journal of Interferon & Cytokine Research. 36(3). 204–214. 1 indexed citations
5.
Vallet, Sophie, Hélène Le Guillou‐Guillemette, Pascal Veillon, et al.. (2015). Duplication of the V3 domain in hepatitis C virus (1b) NS5A protein: Clonal analysis and physicochemical properties related to hepatocellular carcinoma occurrence. Journal of Clinical Virology. 74. 19–25. 1 indexed citations
6.
Ducancelle, Alexandra, Adeline Pivert, Pascal Veillon, et al.. (2014). Interest of Human Papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions. Archives of Gynecology and Obstetrics. 290(2). 299–308. 18 indexed citations
7.
Lunel‐Fabiani, Françoise, Wael Mansour, Frédéric Le Gal, et al.. (2013). Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: A cross sectional study. Journal of Infection. 67(5). 448–457. 38 indexed citations
8.
Patouraux, Stéphanie, Stéphanie Bonnafous, Cosmin Sebastian Voican, et al.. (2012). The Osteopontin Level in Liver, Adipose Tissue and Serum Is Correlated with Fibrosis in Patients with Alcoholic Liver Disease. PLoS ONE. 7(4). e35612–e35612. 65 indexed citations
9.
Mansour, Wael, Pascal Veillon, Alexandra Ducancelle, et al.. (2012). Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. Journal of Medical Virology. 84(8). 1186–1198. 60 indexed citations
10.
Calès, Paul, Philippe Halfon, Dominique Batisse, et al.. (2010). Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. Journal of Hepatology. 53(2). 238–244. 35 indexed citations
11.
Veillon, Pascal, Yves Gallois, Valérie Moal, et al.. (2010). Assessment of new hyaluronic acid assays and their impact on FibroMeter scores. Clinica Chimica Acta. 412(3-4). 347–352. 11 indexed citations
12.
Veillon, Pascal. (2007). Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy. World Journal of Gastroenterology. 13(8). 1195–1195. 19 indexed citations
13.
Calès, Paul, Pascal Veillon, Anselme Konaté, et al.. (2007). Reproducibility of blood tests of liver fibrosis in clinical practice. Clinical Biochemistry. 41(1-2). 10–18. 51 indexed citations
14.
Causse, Xavier, Si Nafa Si Ahmed, Jacques Gros, et al.. (2005). Treatment of chronic hepatitis C in patients unresponsive to interferon. Gastroentérologie Clinique et Biologique. 29(2). 117–121. 1 indexed citations
15.
Veillon, Pascal, Christopher Payan, Catherine Gaudy, A Goudeau, & F. Lunel. (2004). Analyse des mutations des domaines ISDR et V3 de la protéine NS5A du virus de l'hépatite C avant le traitement par l'interféron avec ou sans ribavirine. Pathologie Biologie. 52(9). 505–510. 16 indexed citations
16.
Lunel, F. & Pascal Veillon. (2003). Communication brèveAntigène et charge viraleAntigen and viral load. Transfusion Clinique et Biologique. 10(2). 1 indexed citations
17.
Lunel, F. & Pascal Veillon. (2003). Antigène et charge virale. Transfusion Clinique et Biologique. 10(2). 74–77. 1 indexed citations
18.
Lunel, F., Pascal Veillon, I. Fouchard‐Hubert, et al.. (2003). Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen. Journal of Hepatology. 39(5). 826–833. 24 indexed citations
19.
20.
Gaudy, Catherine, Alain Moreau, Pascal Veillon, et al.. (2003). Significance of Pretreatment Analysis of Hepatitis C Virus Genotype 1b Hypervariable Region 1 Sequences To Predict Antiviral Outcome. Journal of Clinical Microbiology. 41(8). 3615–3622. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Marshall Breakdown of academic impact, for papers by Amal Gad Breakdown of academic impact, for papers by V Weich Breakdown of academic impact, for papers by Montserrat Maldonado‐González Breakdown of academic impact, for papers by M. Willems Breakdown of academic impact, for papers by Galia Askarieh Breakdown of academic impact, for papers by Zu-Yau Lin Breakdown of academic impact, for papers by T Sodeyama Breakdown of academic impact, for papers by I. Lonjon Breakdown of academic impact, for papers by R. Stemerowicz
Rankless by CCL
2026